Idaho Tech Preparing for Regulatory Clearance, Launch of Blood Culture ID, GI Panels | GenomeWeb

NEW YORK (GenomeWeb News) – Idaho Technology today said that it anticipates commercially launching its blood culture ID and gastrointestinal panels by early 2014.

In an update on the company's clinical pipeline, Idaho Technology CEO Kirk Ririe said that clinical trials for the BCID panel have begun while the clinical evaluation of the GI panel is expected to launch in the first quarter of 2013.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The White House has created a list of cuts, including to the NIH, that could be in a budget bill for this year.

The US National Institutes of Health is to allow applicants to cite preprints just as they would any other research paper, ScienceInsider reports.

Two manuscript pages handwritten by Charles Darwin are going on the auction block, according to the Los Angeles Times.

In PNAS this week: tool to track transcriptome-wide binding, evidence of balancing selection on behavior-linked genes, and more.